Five Nasdaq Composite companies are set to beat earnings estimates. These are: EXPE, IDXX, SNY, TW and SEDG.
The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps.
The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps.
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IDEXX's (IDXX) rapid assay revenue growth is supported by solid volume gains in the United States and benefits from net price increases.

5 Stocks Powering Nasdaq ETF to Start 2023

12:48pm, Friday, 13'th Jan 2023
The rally has been broad-based. And the high beta and high growth sector took charge, with the tech-heavy Nasdaq Composite Index rising 5.1% in the initial two weeks of 2023.
VolitionRx Ltd (NYSE-A:VNRX) has announced the availability of its Nu.Q Vet Cancer Test through the IDEXX Laboratories Inc reference laboratory network in the US. The Henderson, Nevada-based multi-na

7 Nasdaq Stocks to Buy and Hold Forever

05:39pm, Sunday, 08'th Jan 2023
After watching the Nasdaq lose roughly a third of its value in 2022, investors might rightly be wary of that particular stock exchange. However, the truth is that there are still plenty of Nasdaq stoc
WESTBROOK, Maine , Dec. 22, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Goldman Sachs Healthcare CEOs Unscripte

The 7 Best Stocks to Buy for 2023

04:26pm, Wednesday, 14'th Dec 2022
There are just a couple of weeks left in 2022. I've been tasked with selecting the seven best stocks to buy for 2023.
IDEXX's (IDXX) international revenues are primarily aided by gains in CAG and Water businesses.
This 137% growth for IDXX stock since late 2018 can primarily be attributed to 1 the company's P/S ratio rising 53% to 11.1x trailing revenues, from 7.3x in 2018, 2.
IDEXX's (IDXX) Q3 top-line performance rides on strong CAG Diagnostics recurring revenue growth.
IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - CEO Conference Call Participants Chris Schot

Why IDEXX Stock Popped Today

10:44am, Tuesday, 01'st Nov 2022
The animal healthcare company beat estimates on the top and bottom lines.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE